Payment overview · 2025
General Payments
$337.82
9 reported records · 3 companies
Healthcare provider profile · identity verified
Leon Robinson, MD
Allopathic & Osteopathic Physicians|Surgery · JEFFERSON CITY, MO · NPI 1871743104
Verified facts
What the public records show
CMS Open Payments records show Leon Robinson, MD received $337.82 in general payments during 2025 across 9 reported records.
Organogenesis Inc. accounted for 68.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Organogenesis Inc. | Unresolved — no canonical attribution shown | $231.01 | 68.4% | 4 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $66.28 | 19.6% | 3 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $40.53 | 12.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $337.82 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| PURAPLY WOUND MATRIX Normalized: puraply wound matrix |
Device | Organogenesis Inc. | $210.92 | 3 | 2025 |
Source payment records
|
|||||
| AFFINITY Normalized: affinity |
Medical Supply | Organogenesis Inc. | $104.37 | 2 | 2025 |
Source payment records
|
|||||
| APLIGRAF Normalized: apligraf |
Device | Organogenesis Inc. | $84.28 | 1 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $66.28 | 3 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $40.53 | 2 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $40.53 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 736 | 53 |
| Furosemide | Furosemide | 705 | 55 |
| Eliquis | Apixaban | 391 | 27 |
| Atorvastatin Calcium | Atorvastatin Calcium | 373 | 48 |
| Potassium Chloride | Potassium Chloride | 338 | 48 |
| Gabapentin | Gabapentin | 253 | 33 |
| Tamsulosin Hcl | Tamsulosin Hcl | 233 | 28 |
| Amlodipine Besylate | Amlodipine Besylate | 217 | 33 |
| Lisinopril | Lisinopril | 207 | 31 |
| Pantoprazole Sodium | Pantoprazole Sodium | 173 | 28 |
| Donepezil Hcl | Donepezil Hcl | 163 | 23 |
| Tramadol Hcl | Tramadol Hcl | 159 | 33 |
| Metformin Hcl | Metformin Hcl | 155 | 22 |
| Losartan Potassium | Losartan Potassium | 145 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 142 | 29 |
| Sertraline Hcl | Sertraline Hcl | 135 | 22 |
| Omeprazole | Omeprazole | 134 | 25 |
| Trazodone Hcl | Trazodone Hcl | 129 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 120 | 12 |
| Mirtazapine | Mirtazapine | 112 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 14 |
| Metoprolol Succinate | Metoprolol Succinate | 111 | 18 |
| Carvedilol | Carvedilol | 110 | 15 |
| Jardiance | Empagliflozin | 109 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 108 | 15 |
| Myrbetriq | Mirabegron | 102 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 101 | 12 |
| Famotidine | Famotidine | 100 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 95 | 15 |
| Memantine Hcl | Memantine Hcl | 95 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 92 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 89 | 25 |
| Quetiapine Fumarate | Quetiapine Fumarate | 88 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 77 | 51 |
| Alprazolam | Alprazolam | 76 | 22 |
| Levofloxacin | Levofloxacin | 75 | 43 |
| Buspirone Hcl | Buspirone Hcl | 70 | 15 |
| Allopurinol | Allopurinol | 68 | suppressed |
| Aripiprazole | Aripiprazole | 68 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 62 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 61 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 60 | suppressed |
| Celecoxib | Celecoxib | 57 | suppressed |
| Lorazepam | Lorazepam | 54 | suppressed |
| Meloxicam | Meloxicam | 54 | suppressed |
| Simvastatin | Simvastatin | 54 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 53 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 53 | suppressed |
| Novolog | Insulin Aspart | 53 | 11 |
| Risperidone | Risperidone | 52 | suppressed |
| Spironolactone | Spironolactone | 52 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 50 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 49 | 49 |
| Fluoxetine Hcl | Fluoxetine Hcl | 47 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 45 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 45 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 44 | 11 |
| Montelukast Sodium | Montelukast Sodium | 44 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 44 | suppressed |
| Baclofen | Baclofen | 43 | suppressed |
| Olanzapine | Olanzapine | 42 | suppressed |
| Pregabalin | Pregabalin | 40 | suppressed |
| Finasteride | Finasteride | 39 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 39 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 37 | suppressed |
| Glipizide | Glipizide | 36 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 35 | suppressed |
| Hydrocortisone | Hydrocortisone | 33 | suppressed |
| Lamotrigine | Lamotrigine | 33 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 32 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 32 | 12 |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Lacosamide | Lacosamide | 31 | suppressed |
| Primidone | Primidone | 31 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 30 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 30 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 29 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 29 | suppressed |
| Xifaxan | Rifaximin | 29 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 28 | 14 |
| Ceftriaxone | Ceftriaxone Sodium | 28 | 18 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 28 | 12 |
| Entresto | Sacubitril/Valsartan | 27 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 27 | 17 |
| Clonazepam | Clonazepam | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 17 |
| Lidocaine Hcl | Lidocaine Hcl | 26 | 20 |
| Propranolol Hcl | Propranolol Hcl | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 25 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 25 | suppressed |
| Latanoprost | Latanoprost | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Klayesta | Nystatin | 24 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Vraylar | Cariprazine Hcl | 24 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 23 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 13 |
| Clonidine | Clonidine | 22 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | 12 |
| Digoxin | Digoxin | 21 | suppressed |
| Levetiracetam | Levetiracetam | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 20 | suppressed |
| Belsomra | Suvorexant | 20 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Nystatin | Nystatin | 20 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 19 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 18 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 18 | suppressed |
| Phenytoin | Phenytoin | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | 13 |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Gemtesa | Vibegron | 17 | suppressed |
| Januvia | Sitagliptin Phosphate | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | suppressed |
| Ondansetron Odt | Ondansetron | 17 | suppressed |
| Prednisone | Prednisone | 17 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 16 | suppressed |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 15 |
| Rivastigmine | Rivastigmine | 16 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Methadone Hcl | Methadone Hcl | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | 11 |
| Estradiol | Estradiol | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 14 | suppressed |
| Novolin R | Insulin Regular, Human | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Hysingla Er | Hydrocodone Bitartrate | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 13 | suppressed |
| Sucralfate | Sucralfate | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Humalog | Insulin Lispro | 12 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Ramipril | Ramipril | 12 | suppressed |
| Ranolazine Er | Ranolazine | 12 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Restasis | Cyclosporine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $337.82 · 9 records | Organogenesis Inc. | AFFINITY, APLIGRAF, COLLAGENASE SANTYL, Kerecis GraftGuide, Kerecis SurgiClose, PURAPLY WOUND MATRIX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error